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Summary  Treatment  of  infectious  diseases  with  antimicrobials  constituted  a  great
achievement  in  the  history  of  medicine.  Unfortunately,  the  emergence  of  resistant
strains  of  bacteria  to  all  classes  of  antimicrobials  limited  their  efﬁcacy.  The  present
study  was  aimed  at  evaluating  the  effect  of  combinations  of  antibiotics  on  multi-drug
resistant  Gram-negative  (MDRGN)  bacteria.
A  liquid  micro-broth  dilution  method  was  used  to  evaluate  the  antibacterial  activ-
ity  of  10  different  classes  of  antimicrobials  on  20  bacterial  strains  belonging  to
six  different  species.  The  antimicrobials  were  associated  with  phenylalanine  ˇ-
naphthylamide  (PAN),  an  efﬂux  pump  inhibitor,  and  with  other  antimicrobials  at
their  sub-inhibitory  concentrations.  The  effectiveness  of  each  combination  was  mon-
itored  using  the  minimal  inhibitory  concentration  (MIC)  and  the  fractional  inhibitory
concentration  (FIC).
Most  of  the  antimicrobials  tested  showed  low  antibacterial  activity  with  a  MIC
value  of  128  mg/L  on  a  majority  of  the  bacterial  strains,  justifying  their  multidrug-
resistant  (MDR)  proﬁle.  Synergistic  effects  were  mostly  observed  (FIC  ≤  0.5)  when
ampicillin  (AMP),  cloxacillin  (CLX),  erythromycin  (ERY),  chloramphenicol  (CHL),
kanamycin  (KAN)  and  streptomycin  (STR)  were  combined  with  tetracycline  (TET)
at  the  sub-inhibitory  concentration  of  MIC/5  or  MIC/10.The  results  of  the  present  work  suggest  that  the  association  of  several  antimicro-
provbials  with  TET  could  im©  2014  King  Saud  Bin  Abdula
Limited.  All  rights  reserved
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ntroduction
n  the  twenty-ﬁrst  century,  infectious  diseases
ontinue to  ravage  the  human  population,  and
hey account  for  approximately  half  of  the
ortality rates  in  tropical  countries.  These  alarm-
ng statistics  indicate  their  devastating  nature.
nfortunately, the  worldwide  dissemination  of
ulti-drug-resistant  bacteria  has  severely  reduced
he efﬁcacy  of  antibacterial  agents,  thus  increasing
herapeutic  failures  [1]. One  of  the  major  antibi-
tic resistance  mechanisms  utilized  by  bacteria  is
ctive efﬂux.  Efﬂux  pumps  (EPs)  involved  in  this
ype of  resistance  are  membrane-associated  active
ransporters  promoting  the  extrusion  of  toxic  com-
ounds,  including  antimicrobials.  This  extrusion
ecreases the  intracellular  concentration  of  antimi-
robials  and  reduces  the  susceptibility  of  bacterial
trains to  these  drugs.  Therefore,  antibiotic  ther-
py has  more  than  ever  become  a  challenge  for
cientists,  and  new  means  of  tackling  resistant
acteria are  urgently  needed.  The  use  of  syner-
istic antibiotic  association  is  an  appealing  way  to
ptimize good  results  during  antibiotherapy  [2].
lthough antibiotic  combinations  have  long  been
sed against  multiple  potential  pathogens  in  the
nitial empirical  treatment  of  critically  ill  patients,
he selection  of  such  drugs  and  their  potential  for
roviding  increased  activity  in  combination  should
e made  with  particular  attention  to  minimize  any
egative  interactions  [3]. This  work  was  aimed  at
valuating  the  effect  of  antibiotic  combinations
gainst MDRGN  bacteria.
aterial and methods
hemicals for antimicrobial assays
etracycline  (TET),  doxycycline  (DOX),  cefepime
FEP), streptomycin  (STR),  ciproﬂoxacin  (CIP),  nor-
oxacin (NOR),  chloramphenicol  (CHL),  cloxacillin
CLX),  ampicillin  (AMP),  erythromycin  (ERY),
nd kanamycin  (KAN)  (Sigma-Aldrich,  St  Quentin
allavier,  France)  were  used  as  reference  antibi-
tics.  p-Iodonitrotetrazolium  chloride  (INT)  and
henylalanine  arginine  -naphthylamide  (PAN)
ere  used  as  microbial  growth  indicators  and  efﬂux
ump inhibitors  (EPIs),  respectively.
acterial strains and culture mediahe  studied  microorganisms  included  reference
American Type  Culture  Collection)  and  clini-
al (laboratory  collection)  strains  of  Providencia
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tuartii,  Pseudomonas  aeruginosa,  Klebsiella  pneu-
oniae, Escherichia  coli,  Enterobacter  aerogenes
nd Enterobacter  cloacae.  The  bacterial  strains  and
heir characteristics  were  previously  reported  [4],
s shown  in  Table  S2.  The  preliminary  treatment  of
hese organisms  and  the  culture  media  were  pre-
ared as  described  in  a previous  study  [5].
ntibiotic susceptibility tests
ntibiotic  susceptibility  tests  using  single
ntimicrobials  and  in  combination  with  PAN
he MICs  of  each  of  the  10  antimicrobials  used  were
etermined  for  20  bacterial  strains  using  the  rapid
NT colorimetric  assay  [6,7].  One  hundred  micro-
iters of  prepared  antimicrobial  was  added  in  the
rst well  of  each  column  of  a  micro  titer  plate
ontaining 100  l  of  broth  in  each  well  and  were
han serially  diluted  twofold.  Next,  100  l  of  the
noculum  prepared  in  Mueller  Hinton  broth  (MHB,
igma-Aldrich)  was  added  to  have  a ﬁnal  concen-
ration of  106 UFC/ml.  The  ﬁnal  concentration  of
MSO was  2.5%  and  did  not  affect  the  microbial
rowth. The  plates  were  covered  with  a sterile
late sealer  and  were  agitated  to  mix  the  content
f the  wells  using  a  shaker.  The  MICs  of  the  samples
ere  determined  after  18  h  of  incubation  at  37 ◦C,
ollowing  the  addition  (40  l)  of  0.2  mg/ml  INT  and
ncubation  at  37 ◦C  for  30  min  [8,9]. The  MIC  was
eﬁned  as  the  lowest  concentration  of  antimicro-
ial that  prevented  color  change  of  the  medium  and
xhibited  complete  inhibition  of  microbial  growth
6,8].
he role  of  efﬂux  pumps  in  the  susceptibility  of
ram-negative bacteria  to  the  antimicrobials
sed  in  this  study
he  antibacterial  susceptibility  test  in  the  pres-
nce of  the  efﬂux  pump  inhibitor  was  carried  out
fter the  twofold  serial  dilution  by  adding  20  l
f PAN  (ﬁnal  concentration  of  PAN  20  mg/L)  to
00 l  of  MHB  in  the  wells  of  the  micro  titer  plate.
hen, 80  l  of  the  inoculum  was  introduced  to
btain a ﬁnal  concentration  of  106 UFC/ml.  Wells
ontaining  MHB,  100  l of  inoculum,  and  DMSO  at
 ﬁnal  concentration  of  2.5%  served  as  negative
ontrols (this  internal  control  was  systematically
dded). The  total  volume  in  each  well  was  200  l.
he MICs  of  the  antimicrobials  were  obtained
fter 18  h of  incubation  at  37 ◦C,  as  mentioned
bove.he inhibitory  activity  of  the  combined
ntimicrobials
he  MICs  of  the  two  combined  antimicrobials  were
onitored  as  follows:  100  l  of  the  antibiotic,  A1,
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Table  1  The  minimal  inhibitory  concentration  of  the  studied  antimicrobials  on  the  different  bacterial  species.
Bacteria  Antimicrobials  and  MICs  (mg/L)
B-lactams  Tetracycline  Quinolones  Macrolides  Phenicol  Aminosides
AMP  CLOX  TET  DOX  NOR  CIP  ERY  CHL  KAN  STR
E.  coli
ATCC8739  —  —  64  64  2  64  128  —  —  128
AG100Atet  —  —  64  64  8  64  64  —  —  64
AG100  64  32  8  1  128  2  32  8  16  64
MC4100  —  32  8  8  128  64  64  <1  —  —
E.  aerogenes
ATCC13048 —  —  16  8  <1  32  64  16  4  16
EA3  —  —  16  32  128  64  —  64  —  64
EA289  —  128  64  32  128  128  64  —  <1  32
EA298  —  —  16  128  nd  2  128  32  —  64
EA27  —  128  32  16  32  32  32  —  16  32
K.  pneumoniae
ATCC11296 —  —  32  32  <1  <1  —  16  128  —
KP63  128  128  16  8  8  32  64  64  —  64
K2  —  —  32  16  32  128  64  64  128  128
K24  —  —  32  32  64  64  128  32  —  64
P.  aeruginosa
PA01 —  —  16  16  128  32  64  32  —  128
PA124 —  —  16  16  64  128  64  128  64  64
E.  cloacae
ECCI69  —  —  32  <1  <1  128  64  —  —  64
BM47  —  128  32  16  —  128  128  —  —  8
BM67  —  —  16  32  64  —  128  64  64  32
P.  stuartii
PS2636  —  128  —  64  128  64  —  —  64  —
PS299645  —  —  —  16  8  64  32  16  <1  64
NAE16  —  64  32  16  32  128  64  64  2  128
‘—’ represents >128 mg/L.
MIC, Minimal inhibitory concentration; AMP, Ampicillin; CLOX, Cloxacillin; TET, Tetracycline; DOX, Doxycyclin; NOR, Norﬂoxacin;
CIP, Ciproﬂoxacin; ERY, Erythromycin; CHL, Chloramphenicol; KAN, Kanamycin; STR, Streptomycin; E. coli, Escherichia coli;
K. pneumonia,  Klebsiella pneumoniae; P. aeruginosa,  Pseudomonas aeruginosa;  E. cloacae,  Enterobacter cloacae; P. stuartii,
Providencia stuartii.
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cwas  introduced  in  the  ﬁrst  well  of  each  column
of the  micro  titer  plate.  After  the  twofold  serial
dilution, 20  l  of  the  second  antibiotic,  A2,  was
introduced at  concentrations  of  MIC/5  or  MIC/10,
as determined  in  a  preliminary  assay  using  the  MDR
strain of  P.  aeruginosa  PA124.  Then,  80  l  of  the
inoculum (bacteria)  was  added  into  each  well  of
the plate  to  a  ﬁnal  concentration  of  106 UFC/ml.
The MIC  obtained  was  that  of  A1  in  the  presence  of
20 l  of  A2.  The  fractional  inhibitory  concentration
(FIC) was  calculated  as  previously  described  [10].
The results  were  interpreted  as  follows:FIC  ≤  0.5  (synergy),  0.5  <  FIC  ≤  4  (indifference)
and FIC  >  4 (antagonism).
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ntibiotic susceptibility testing using single
ntimicrobials and in combination with
AN
he  results  of  the  antibacterial  activity  of  the  single
ntimicrobials  on  a panel  of Gram-negative  bacte-
ia are  summarized  in  Table  1.
These  results  show  that  the  studied  bacteria
pecies were  weakly  sensitive  to  most  of  the  antimi-
robials  tested,  with  MIC  values  equal  to  or  greater
han 128  mg/L.  The  10  most  resistant  strains  among
he 20  tested  bacteria  were  selected,  and  their
usceptibilities to  antimicrobials  were  determined
n the  presence  of  PAN  to  determine  whether
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 im
proved
 the
 efﬁciency
 of
 M
D
RG
N
 
229
Table  2  The  minimal  inhibitory  concentration  of  the  studied  antimicrobials  in  the  presence  and  absence  of  PAN  on  10  MDR  strains  of  bacteria.
Antimicrobials  Bacteria  and  MIC  (mg/L)
E.  coli E.  aerogenes K.  pneumoniae P.  aeruginosa E.  cloacae P.  stuartii
ATCC8739 AG100Atet  EA3  EA298  KP63  PA124  ECCI69  BM47  PS2636  PS299645
PAN >1024  >1024  1024  >1024  1024  1024  >1024  1024  >1024  >1024
AMP
−PAN —  —  —  —  —  —  —  —  —  —
+PAN —  —  —  —  —  —  —  —  —  —
CLX
−PAN —  —  —  —  128  —  512  —  128  —
+PAN —  —  —  —  —  —  —  —  —  —
TET
−PAN 128  64  —  16  16  16  32  —  —  —
+PAN 64  8  32  64  64  16  16  128  64  16
DOX
−PAN 64  64  32  128  8  16  <1  16  64  16
+PAN  8  <1  2  32  1  <0.5  <0.5  8  2  <0.5
CIP
−PAN  128  64  64  2  64  128  128  128  128  64
+PAN  32  32  32  4  32  64  64  64  64  32
NOR
−PAN  2  8  128  <1  8  64  <1  —  128  8
+PAN  64  4  128  64  4  32  —  —  16  64
ERY
−PAN  128  64  32  64  64  —  64  64  —  32
+PAN  64  128  16  16  32  16  8  32  64  16
CHL
−PAN  —  64  —  —  —  128  —  —  —  —
+PAN  128  32  128  32  32  64  64  64  128  32
KAN
−PAN  —  —  <1  —  —  64  —  —  64  <1
+PAN  —  —  —  —  128  512  —  —  32  64
STR
−PAN  128  128  64  —  64  128  64  8  —  64
+PAN  —  2  <1  32  32  64  32  2  —  32
‘—’ represents >128 mg/L; AMP,: ampicillin; CLX, cloxacillin; TET, tetracycline; DOX, doxycycline; CIP, ciproﬂoxacin; NOR, norﬂoxacin; ERY, erythromycin; CHL, chloramphenicol; KAN,
kanamycin; STR, streptomycin; MDR, Multi-Drug Resistant; (+PAN), in presence of 20 mg/L of PaN; (−PAN), in the absence of PAN.
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Table  3  The  MICs  of  different  antimicrobials  after  their  association  with  subinhibitory  concentrations  of  tetracycline  against  ten  MDR  bacterial  strains.
Antimicrobials  Bacterial  strains,  MIC  (mg/L)  of  antimicrobials  and  fold  increase  (in  parenthesis)  of  some  antimicrobials  combine  with  TET
TET  con-
centration
PA124 ATCC8739 AG100ATet EA3  EA298  ECCI69  BM47  KP63  PS2636  PS299645
AMP  0  —  —  —  —  —  —  —  128  —  —
MIC/10  ≤0.5
(≥1024)S
64  (>4)S ≤0.5
(≥1024)S
≤0.5
(≥1024)S
>64  32  (≥16)S ≤0.5
(≥1024)S
64  (2)S >64  ≤0.5
(≥1024)S
CLX  0  —  —  —  —  —  —  128  128  128  —
MIC/5  ≤0.5
(≥1024)S
>64  ≤0.5
(≥1024)S
≤0.5
(≥1024)S
≤0.5
(≥1024)S
≤0.5
(≥1024)S
≤0.5
(≥256)S
≤0.5
(≥256)S
>64  (≥128)S ≤0.5
(≥1024)S
ERY  0  64  128  64  —  128  64  128  64  —  32
MIC/5  ≤0.5
(≥128)S
0.5  (256)S ≤0.5
(≥128)S
≤0.5
(≥1024)S
≤0.5
(≥256)S
≤0.5
(≥128)S
≤0.5
(≥256)S
≤0.5
(≥128)S
32  (≥16)S ≤0.5
(≥64)S
CHL  0  128  —  —  64  32  —  —  64  —  32
MIC/5  ≤0.5
(≥256)S
32  (>16)S ≤0.5
(≥1024)S
≤0.5
(≥128)S
≤0.5
(≥64)S
≤0.5
(≥1024)S
≤0.5
(≥1024)S
≤0.5  (128)S 64  (≥8)S ≤0.5
(≥64)S
KAN  0  256  —  —  —  —  —  —  —  64  ≤4
MIC/10  ≤2  (≥128)S ≤4  (≥128)S —  ≤4  (≥128)S 64  (≥8)S >6464
(≥16)S
128  (≥4)S ≤4  (≥128)S 64  (1)I ≤4
STR  0  128  128  64  —  64  64  8  64  64  128
MIC/5  ≤0.5
(≥256)S
4  (32)S ≤0.5
(≥128)S
≤0.5
(≥1024)S
≤0.5
(≥128)S
≤0.5
(≥128)S
≤0.5
(≥16)S
≤0.5
(≥128)S
>64  ≤0.5
(≥256)S
‘—’ represents ≥512r; AMP, ampicillin; CLX, cloxacillin; TET, tetracycline; DOX, doxycycline; CIP, ciproﬂoxacin; NOR, norﬂoxacin; ERY, erythromycin; CHL, chloramphenicol; KAN,
kanamycin; STR, streptomycin; (S), synergy; (I), indifference.
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oetracycline  improved  the  efﬁciency  of  MDRGN  
hey  over-express  active  efﬂux  pumps.  The  results
ummarized  in  Table  3 show  that  PAN  alone  had
o intrinsic  activity  at  the  concentration  used
MIC ≥  1024  mg/L  on  most  of  the  strains).  The  activ-
ty of  a  majority  of  antimicrobials  increased  slightly
n the  presence  of  PAN.  This  was  observed  with
IP, ERY,  DOX,  CHL  and  STR  (Table  2).  However,
he largest  increase  in  the  activity  of  antimicrobials
n the  presence  of  PAN  was  observed  with  DOX,
hich displayed  better  activity  on  all  10  bacterial
trains (a  4-  to  12-fold  decrease  of  the  MICs).  These
bservations  conﬁrm  the  fact  that  the  antimicro-
ials used  here  are  expelled  out  of  the  bacterial  cell
n the  absence  of  EPI.  In  contrast  to  the  antimicro-
ials of  other  classes,  the  activity  of  -lactam  (in
he presence  of  the  pump  inhibitor  PAN)  remains
nchanged. Meanwhile,  the  association  of  NOR  and
AN led  to  the  reduction  of  the  antibacterial
ctivity  of  NOR,  suggesting  possible  antagonistic
ffects.
ntibiotic susceptibility tests using
ombined antimicrobials
he  studied  antimicrobials  were  also  combined
n pairs  (A1  and  A2)  with  A2  tested  at  sub-
nhibitory concentrations  against  10  MDR  bacterial
trains.  A preliminary  study  was  conducted  using  P.
eruginosa  PA124  (supporting  information  in  Table
2). The  lowest  sub-inhibitory  concentrations  of
2 that  resulted  in  the  lowest  MIC  of  A1  were
IC/5 in  most  cases  on  P.  aeruginosa  PA124.  How-
ver, two  cases  of  association  at  MIC/10  (AMP  +  TET
nd KAN  +  TET)  were  noted.  The  sub-inhibitory  con-
entration  of  A2  that  permitted  the  best  activity
f A1  was  further  extended  to  the  other  nine
acterial strains.  The  fractional  inhibitory  concen-
ration  obtained  with  most  associations  was  less
han or  equal  to  0.5  (FIC  ≤  0.5),  representing  syn-
rgistic  activity  between  the  two  antimicrobials.
his synergism  was  mainly  observed  in  the  asso-
iation  of  tetracycline  (TET  and  DOX  as  A2)  to
ther antimicrobials.  Therefore,  TET  was  selected
s antimicrobial  A2  and  tested  in  association  with
ther antimicrobials  on  MDR  bacteria  (Table  3).
he results  clearly  showed  that  TET  at  MIC/5
nd MIC/10  signiﬁcantly  improved  the  activity
f other  antimicrobials.  More  than  a  1024-fold
ncrease was  obtained  when  TET  was  combined
ith AMP,  CLX,  and  CHL  against  the  majority  of
he studied  MDR  bacteria.  Additionally,  no  cases
f antagonism  were  observed  when  the  antimi-
robials under  study  were  combined  with  TET
Table  3).
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he antibacterial activity of  different
ntimicrobials
 weak  sensitivity  of  bacterial  strains  to  the  antimi-
robials  was  observed.  This  is  not  surprising  given
hat the  strains  expressed  several  mechanisms  of
esistance including  active  efﬂux  [11].  Although  the
ajority of  bacterial  strains  were  weakly  sensi-
ive, variations  were  observed  in  the  activity  of
he antimicrobials.  These  variations  may  be  due
o intrinsic  factors  speciﬁc  to  each  microorganism.
hese results  corroborate  previous  data,  indicating
hat the  activity  of  the  active  principle  can  vary
rom one  species  to  another  or  from  one  strain  to
nother  [12].
It  was  also  observed  that  the  activity  of  antimi-
robials depends  on  their  respective  classes.  It
as observed  that  -lactam  bactericidal  antimicro-
ials were  the  less  active  class  of  antimicrobials.
his can  be  explained  by  the  production  of  -
actamases  and/or  the  reduction  of  porins  located
t the  external  membrane  of  bacteria  that  are  the
rincipal  resistance  mechanisms  of  bacteria  such
s Klebsiella  pneumoniae  to  -lactams  [1].  Con-
ersely,  the  inhibitory  activity  of  antimicrobials
f the  same  class  varies  from  one  compound  to
nother  (Table  1).  This  was  the  case  for  NOR  and
IP (two  quinolones)  on  different  strains  of  E.  coli.
his variation  between  antimicrobials  of  the  same
lass could  be  explained  by  the  structural  differ-
nce between  the  two  compounds  as  the  ethyl
roup of  NOR  is replaced  by  a  cyclopropyl  group
n CIP.
he role of efﬂux pumps in the
usceptibility of Gram-negative bacteria to
ntimicrobials
AN  is  an  arylpiperazine  that  inhibits  RND
Resistance-Nodulation-cell  Division)  pumps  by
ompetition  with  antimicrobials  for  target  sites
13,14]. To  determine  the  role  of  efﬂux  pumps  in
his work,  the  concentration  of  PAused  (20  g/ml)
id not  exert  any  intrinsic  effect  on  the  bacteria,
s previously  demonstrated  [15]. The  antibacte-
ial activity  of  -lactams  was  not  improved  by  the
resence  of  PAN.  This  can  be  explained  by  the
on-implication  of  efﬂux  pumps  in  the  mechanism
f resistance  of  these  strains  to  -lactams.  Addi-
ionally,  the  targets  of  -lactams  are  located  in  the
acterial coast;  thus,  the  efﬂux  provides  another
ossibility for  re-entering  the  bacterial  cell,  show-
ng that  the  inhibition  of  the  efﬂux  pumps  could
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reduce  this  activity.  These  results  corroborate  pre-
vious data  [16], which  showed  that  the  addition
of efﬂux  pumps  inhibitors.  Naphthylmethyl  phenyl-
alanine  (NMP)  and  phenylalanine  -naphthylamide
(PAN) has  no  effect  on  the  MIC  of  AMP  and  peni-
cillin, which  are  two  -lactams.  In  contrast,  the
signiﬁcant  decrease  in  the  MIC  values  of  DOX  in
the presence  of  PAN  suggests  that  this  antibi-
otic could  be  a  substrate  of  the  type  of  efﬂux
pumps involved  in  the  resistance  of  the  strains
used here.  However,  Lamers  et  al.  [17]  demon-
strated last  year  that  at  concentrations  equal  to
25 mg/L  and  above,  PAN  also  increases  the  activ-
ity of  antimicrobials  through  the  permeabilization
of bacterial  membranes,  which  increases  the  intra-
cellular  concentration  of  antimicrobials.  However,
this could  not  be  directly  concluded  from  the  results
of this  study  because  the  concentration  (20  mg/L)
used is  lower.  The  results  obtained  regarding  the
association  of  PAN  to  NOR  and  CIP  are  contrary  to
previous  ﬁndings  [18], which  showed  that  PAN  is
the inhibitor  of  efﬂux  pumps  that  expel  quinolones.
These contradictory  results  can  be  explained  by  the
development  of  other  mechanisms  of  resistance,
such as  the  mutation  of  their  targets,  namely,  DNA
gyrase and  topoisomerase  IV  [14]. In  fact,  the  activ-
ity of  CIP  remains  almost  unchanged  in  the  presence
of PaN,  while  that  of  DOX  increased  (resulting  in
decreased  MICs)  on  many  tested  strains  (Table  2).
These differences  could  be  linked  to  the  structural
differences already  mentioned  between  the  two
antimicrobials.
The effects of the association of
antimicrobials
The  synergistic  effects  of  antimicrobials  observed
on many  strains  could  be  due  to  the  presence  of
preferential  substrates  of  efﬂux  pumps  between
the two  combined  antimicrobials,  which  could
allow an  increase  in  the  intracellular  concentra-
tion of  the  second  antimicrobial  in  the  bacterial
cell [19].  The  synergistic  effect  could  also  be  due
to the  presence  of  an  effector  that  ﬁxes  on  its
target site  and  modiﬁes  the  conformation  of  the
sites to  improve  the  entry  and  interaction  of  the
second  antibiotic  with  its  target  [1].  These  effects
could  then  explain  the  different  cases  of  synergisms
observed in  this  study,  speciﬁcally  in  the  experi-
ments using  TET  as  antibiotic  A2.  It  is  generally
admitted that  tetracyclines  possess  bacteriostatic
activity, but  some  previous  studies  revealed  bacte-
ricidal activities  of  these  drugs  and  their  synergistic
effect in  combination  with  different  antimicrobials
[20,21].  The  MDRGN  bacteria  used  in  this  study  are
A
T
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uite  representative  of  the  common  Gram-negative
esistant bacteria  involved  in  human  infectious  dis-
ases, but  it would  be  of  great  importance  to
xtend  the  study  of  the  synergistic  effects  found
ere on  Gram-positive  resistant  bacteria  and  their
ffectiveness  in  vivo.  Additionally,  the  indiffer-
nces observed,  notably  with  the  association  of
AN + TET  and  ERY  +  CIP,  can  be  explained  by  the
ver-expression  of  other  types  of  efﬂux  pumps  by
hese bacterial  strains  [22].  In contrast  to  these
ffects,  the  antagonism  observed  between  NOR  and
IP may  be  due  to  a  negative  effect  of  the  com-
lex formed  by  the  two  compounds,  given  that  both
ntimicrobials  are  quinolones.
onclusion
he  overall  results  obtained  in  this  study  show  that
he association  of  TET  to  antimicrobials  of  other
lasses  leads  to  synergistic  effects.  These  results
rovide  baseline  information  for  the  possible  use
f antimicrobial  combinations,  mostly  between  TET
nd other  antimicrobials,  to  ﬁght  infections  caused
y multi-drug  resistant  bacteria.
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